D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 91,500
-1,000 (-1.08%)
At close: Jan 19, 2026
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 3.98 trillion as of January 16, 2026. Its market cap has increased by 702.21% in one year.
Market Cap
3.98T
Enterprise Value
3.95T
Revenue
8.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
91,500.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 3.98T, an increase of 949.50%. That is a compound annual growth rate of 292.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 3.98T | -0.33% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |